Stenger Family Office, LLC

Family Office

Position in MRK — Merck & Co., Inc.

CIK 2056106 Naperville, IL

Position in MRK

as of Jun 30, 2026 · filed Jul 13, 2026 Compact

Position Value

$678,737

+$77,769 QoQ

Shares Held

5,282

+5.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

#2,442

of 3,769 holders

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stenger Family Office, LLC holds $21,464,934 across 5 Drug Manufacturers - General names. MRK ranks #4 (3.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	33,496	$8,428,933
2	LLY	ELI LILLY & Co	6,754	$8,100,950
3	JNJ	Johnson & Johnson	15,021	$3,814,883
4	MRK	Merck & Co., Inc. This page	5,282	$678,737
5	GILD	Gilead Sciences, Inc.	3,494	$441,431

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$678,737	5,282	+5.7%	Shares	Sole	2026-07-13
2026-03-31	$600,968	4,996	-0.5%	Shares	Sole	2026-04-29
2025-12-31	$528,299	5,019	-0.1%	Shares	Sole	2026-03-04
2025-09-30	$421,832	5,026	-89.7%	Shares	Sole	2025-10-29
2025-06-30	$3,853,350	48,678	+1523.1%	Shares	Sole	2025-08-13
2024-12-31	$298,340	2,999	—	Shares	Sole	2025-02-13
No filing history on record for this holder in this stock.